GSTP1 gene promoter methylation is widely characterized by several independent groups and is found to be have diagnostic value as a biomarker in prostate cancer patient tissue or body fluid aided in non-invasive detection[30]. This evidence concerns the gene GSTP1 and prostate cancer.